Ultomiris Drug Market: A Comprehensive Analysis The Ultomiris drug market is experiencing significant growth, driven by its innovative approach to treating rare complement-mediated disorders. Ultomiris, the brand name for ravulizumab, is a humanized monoclonal antibody developed by AstraZeneca's Alexion Pharmaceuticals. It functions as a long-acting C5 complement inhibitor,...